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THE INHIBITION OF PAINFUL BREAST ENGORGE-
MENT IN THE PUERPERIUM WITH STILBESTROL*
MAX L. BERLOWE
The problem of relieving the pain and discomfort of breast
engorgement in the puerperium, espiecially in the non-nursing
mother, has been an unsatisfactory one. The unhappiness of the
patient and the not infrequent complications of cellulitis and abscess
formation have led to the application of many and varied therapeutic
measures. Heretofore the measures employed, such as tight breast-
binding, restriction of fluids, saline cathartics, ice-packs, hot-packs,
massage, and injections of camphor in oil, have in themselves been
as discomforting as the breast engorgement. At present a physio-
logical approach toward the solution of this difficulty gives great
promise of success in a very high percentage of cases. This has
become possible through a better understanding of the physiology
of lactation and of hormonal therapy.
Though painful engorgement of the breasts is said to be caused
by lymphatic and venous stasis' and not by distention of the ducts
with milk, we know from clinical observation that with evacuation
and drainage of the milk the pain and stasis will quickly subside.
There appears to be a cause and effect relationship between these
two phenomena. If we could, therefore, prevent over-distention
of the ducts we might possibly prevent congestion, stasis, and pain.
In the physiology of lactation two factors play a related role.
The first, a hormonal one, which initiates lactation, and the second,
a neurogenic one, which maintains lactation. The hormonal factor
involves stimulation of the breasts by the ovarian hormones (estro-
gen and progestin) and by the lactogenic principles of the anterior
lobe of the hypophysis. The neurogenic factor is stimulated by
suckling or by pumping of the breasts. This latter factor affords a
mechanical stimulus, the lack of which permits a cessation of the
milk supply. The release of lactogen only occurs when the inhibit-
ing effect of estrogen is withdrawn. This withdrawal occurs only
after delivery.
If our conception of the physiology of lactation is correct it
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could be postulated that by preventing or modifying the hormonal
changes which follow parturition, treatment should be more success-
ful. The use of Stilbestrol appears to do this.
Stilbestrol* is a synthetic hormone-like preparation whose action
is the same as that of the natural estrogens. It is stated to be
about 20 times more active than is estrone and 5 or 6 times more
active than is estradiol benzoate when taken by mouth.4 Its action
is the same as that of the natural estrogens. It can induce a prolif-
eration of the endometrium, abolish deficiency manifestations of the
climacteric, stimulate the growth of a hypoplastic uterus, abolish
the pain of dysmenorrhea, and prevent or inhibit lactation.4
Stilbestrol may be administered orally or intramuscularly. No
matter which route is used certain toxic symptoms, such as nausea,
vomiting, pyrosis, and vertigo, may occur. The severity of these
toxic symptoms is independent of the dosage employed or of route
of administration, e.g., severe reactions occurring with small doses
or nausea and vomiting appearing with intramuscular doses. The
incidence of nausea and vomiting is variable. Some authors report
untoward effects in as high as 30 per cent of cases, while other
authors affirm that it causes disturbance in a very small percentage of
cases. Puerperal women, however, appear to have a tolerance to
the drug, nausea and vomiting very rarely occurring.
This preliminary series covers only 16 cases. Each patient was
given a total of 25 mg. in divided doses; 10 mg. on the day of
delivery or the first day postpartum, and 5 mg. daily thereafter.
The medication was given after meals.t
The nursing orders were as follows: 1) Do not bind breasts,
restrict fluids, use ice-bags or cathartics; 2) Note and record nausea,
vomiting, heart-burn, or dizziness.
Each case was carefully questioned and observed for breast
engorgement, pain, temperature rise, and toxicity. Seven of the
nine multiparous women had previously nursed their infants. The
following table lists each case:
* The estrobene (Stilbestrol) used in this study was kindly supplied by Ayerst,
McKenna and Harrison.
t Since this paper was written the dosage of Stilbestrol has been modified. Pres-
ent treatment consists in the administration of 15 mg. of Stilbestrol (5 mg. T.I.D.
P.C.) for the first 2 days, and 5 mg. daily until the patient is discharged after 10 to
12 days. With this treatment there has been no secondary engorgement, breast
pain, or symptoms of toxicity.
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Primaryengorgement Secondary engorgement
Dose (3-5 day) (7-10 day)
Dose ___A__ -I_ _ Toxic
Case (mg.) pain no pain fever pain no pain feer symptoms Results
1. Para 1 25 ...... slight 0 ...... ...... ...... 0 excellent
2. Para 2 25 ...... ...... ...... ...... slight 0 0 excellent
3. Para 1 25 ...... ...... ...... ...... slight 0 0 excellent
4. Para 2 25 slight ...... 0 ...... slight 0 0 good
5. Para 2 25 ...... slight 0 ...... slight 0 0 excellent
6. Para 1 25 ...... ...... ...... ...... slight 0 0 excellent
7. Para 1 20 ...... slight 0 ...... ...... ...... 0 excellent
8. Para 3 25 ...... slight 0 ...... slight 0 0 excellent
9. Para 2 30 ...... ..... ...... severe ...... 0 0 poor
10. Para 2 25 ...... ...... ...... ...... slight 0 0 excellent
11. Para 1 25 ...... slight 0 severe ...... 0 0 poor
12. Para 2 20 ...... ...... nursed infant after fifth day 0 excellent
13. Para 2 25 ...... ...... ...... ...... slight 0 0 excellent
14. Para 1 25 ...... ...... ...... ...... slight 0 0 excellent
15. Para 1 25 ...... slight 0 ...... ...... 0 excellent
16. Para 3 25 slight ...... 0 ...... ...... 0 good
From this series the following conclusions may be drawn:
Painful engorgement was absent in 88 per cent of the cases.
Lactation was suppressed in all cases, except Case 12.
There occurred both a primary (3rd-5th day) and a secondary
(7th-10th day) engorgement. These were soft, and absolutely
painless in 75 per cent of the cases.
There occurred in many of the cases a leakage of a thin, watery
secretion during the secondary engorgement.
The severe pain was evidenced during the secondary engorge-
ment.
No toxic reactions were noted in any of the cases.
Neither gravidity nor previous nursing had any apparent influ-
ence upon the results.
The temperature rise often seen with breast engorgement was
absent in all instances.
Discussion
The results of this small series parallel those of other investi-
gators. Abarbanel and Goodfriend' found Stilbestrol successful in
85 per cent of their 35 cases in preventing and relieving painful
engorgement of the breasts in the non-nursing mother. Muckle,5
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relieved and decreased by Stilbestrol. Connally et al.3 state that
no patient of their series complained of engorged or painful breasts.
Stewart and Pratt6 state that engorgement of breasts may be pre-
vented by suitable doses of Stilbestrol.
In a control series (no hormones used), Abarbanel and Good-
friend' encountered severe painful engorgement in 47.7 per cent of
cases, mild pain in 44.6 per cent, and no pain in 7.7 per cent.
Though no control series was run in conjunction with the cases
reported in this paper, subsequent study revealed an incidence in
approximately the same proportions.
The onset of lactation can also be retarded or even suppressed.
In retarding the onset, Stilbestrol inhibits the release of lactogen-
by maintaining the estrogenic level following parturition. In the
suppression of lactation, the important factor is not Stilbestrol, but
is the absence of nursing (the nervous stimulus).
Despite the use of the drug, lactation need not be suppressed.
This was shown by Case 12 when the mother, after having received
20 mg. of Stilbestrol, decided to nurse the infant. The ensuing
milk supply was adequate for the infant. Stewart and Pratt' found
a variable individual response in milk production after the use of
Stilbestrol, showing that "inhibition of breast engorgement is not
synonymous with inhibition of lactation."
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